CTRI/2022/02/040026尚未招募未知
A prospective, randomized controlled, open-label, three-arm clinical study to compare and evaluate the effectiveness three different Hydroxypropyl Methylcellulose ophthalmic viscosurgical device in patient undergoing ophthalmic surgery
The Eye Foundation0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Unilateral/Bilateral cataract
- •2.Patients with age >= 45 years.
- •3.Patients with Grade I to III cataract and used OVDs
- •4.Patients that have healthy eyes excluding the formation of cataract.
- •5.Given consent to use device related data for scientific purpose.
排除标准
- •1.Black, Brunescent, traumatic or subluxated cataract.
- •2.Corneal endothelial disease.
- •3.Pregnant lady and lactating mother
- •4.Patient who is part of another device or drug trial.
- •5.Baseline endothelial cell density < 1500 cells/mm2 in the operative eye.
- •6.Patient who had Glaucoma, Pseudo exfoliation Syndrome with Iris atrophy, Proliferative diabetic retinopathy at the time of surgery (Random blood sugar level more than 140 mg/dl).
- •7.A history of chronic or recurrent inflammatory eye disease (e.g. iritis, scleritis, uveitis, Iridocyclitis, rubeosis iritis).
- •8.Previous intra ocular or corneal surgery.
研究者
相似试验
尚未招募
4 期
To compare and evaluate clinical outcome of three different ophthalmic viscoelastic devices during ophthalmic surgeryCTRI/2020/02/023391Biotech Vision Care Pvt Ltd
尚未招募
4 期
Transcendental Meditation for healthcare professionalsCTRI/2024/07/071645SMSIMSR, Sri Sathya Sai University for Human Excellence
招募中
3 期
A prospective, randomised, controlled, open-label, multicentre phase III study to evaluate efficacy and safety of Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-Edotreotide compared to targeted molecular therapy with Everolimus in patients with inoperable, progressive, somatostatin receptor-positive (SSTR+), neuroendocrine tumours of gastroenteric or pancreatic origin (GEP-NET).Neuroendocrine tumor - NET10017991NL-OMON52990ITM Solucin GmbH20
尚未招募
3 期
A randomized, prospective, open-label, controlled trial comparing the efficacy of omitting H2 antagonists versus famotidine in premedication protocol for prophylaxis of taxane hypersensitivity reactionsA randomized, prospective, open-label, controlled trial comparing the efficacy of omitting H2 antagonists versus famotidine in premedication protocol for prophylaxis of taxane hypersensitivity reactionsTCTR20220913005/A140
进行中（未招募）
不适用
Australian BioEnterics Intragastric Balloon (BIB) study in obese subjects with metabolic syndromeACTRN12608000224325Allergan Australia66